US2009035353A1PendingUtilityA1
Non-absorbent articles containing additives
Est. expiryNov 21, 2021(expired)· nominal 20-yr term from priority
A61L 2300/21A61L 2300/216A61K 31/655A61K 31/335A61L 2300/204A61L 15/46A61K 31/381A61K 31/12A61F 13/8405A61L 2300/404A61L 2300/432A61L 2300/202A61K 31/407A61K 31/60A61L 2300/45
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Non-absorbent articles containing an additive are disclosed. The non-absorbent articles include an effective amount of an inhibitory compound such as cerulenin, triclosan, or hexachloroprene, for example, to substantially inhibit the production of TSST-1 by Gram positive bacteria.
Claims
exact text as granted — not AI-modified1 . A tampon applicator comprising a non-absorbent material and an effective amount of a first active ingredient having the general formula:
wherein R 200 is a monovalent, saturated or unsaturated, substituted or unsubstituted hydrocarbyl moiety having from 1 to 15 carbon atoms which may or may not be interrupted with heteroatom, and the first active ingredient is effective in inhibiting the production of TSST-1 from Gram positive bacteria, and wherein the first active ingredient is present in an amount of from about 0.05 micromoles/gram of non-absorbent material to about 5 micromoles/gram of non-absorbent material.
2 - 4 . (canceled)
5 . The tampon applicator as set forth in claim 1 wherein the first active ingredient has the structure of formula (II).
6 . The tampon applicator as set forth in claim 5 wherein the first active ingredient is cerulenin (open structure).
7 . The tampon applicator as set forth in claim 1 wherein the first active ingredient has the structure of formula (III).
8 . The tampon applicator as set forth in claim 7 wherein the first active ingredient is cerulenin (closed structure).
9 . (canceled)
10 . (canceled)
11 . The tampon applicator as set forth in claim 6 wherein the cerulenin (open structure) is present in an amount of from about 0.1 micromoles/gram of non-absorbent material to about 1 micromole/gram of non-absorbent material.
12 . The tampon applicator as set forth in claim 8 wherein the cerulenin (closed structure) is present in an amount of from about 0.1 micromoles/gram of non-absorbent material to about 1 micromole/gram of non-absorbent material.
13 . A non-absorbent article comprising a non-absorbent substrate and an effective amount of a first active ingredient having the general formula:
wherein R 200 is a monovalent, saturated or unsaturated, substituted or unsubstituted hydrocarbyl moiety having from 1 to 15 carbon atoms which may or may not be interrupted with a heteroatom, and the first active ingredient is effective in inhibiting the production of TSST-1 from Gram positive bacteria, and wherein the first active ingredient is present in an amount of from about 0.05 micromoles/gram of non-absorbent article to about 5 micromoles/gram of non-absorbent article.
14 - 16 . (canceled)
17 . The non-absorbent article as set forth in claim 13 wherein the first active ingredient has the structure of formula (II).
18 . The non-absorbent article as set forth in claim 17 wherein the first active ingredient is cerulenin (open structure.
19 . The non-absorbent article as set forth in claim 13 wherein the first active ingredient has the structure of formula (III).
20 . The non-absorbent article as set forth in claim 19 wherein the first active ingredient is cerulenin (closed structure).
21 . (canceled)
22 . (canceled)
23 . The non-absorbent article as set forth in claim 18 wherein the cerulenin (open structure) is present in an amount of from about 0.1 micromoles/gram of non-absorbent article to about 1 micromole/gram of non-absorbent article.
24 . The non-absorbent article as set forth in claim 20 wherein the cerulenin (closed structure) is present in an amount of from about 0.1 micromoles/gram of non-absorbent article to about 1 micromole/gram of non-absorbent article.
25 . The non-absorbent article as set forth in claim 13 wherein the first active ingredient is effective in substantially inhibiting the production of TSST-1 from Staphylococcus aureus bacteria.
26 . The non-absorbent article as set forth in claim 13 wherein the non-absorbent article is selected from the group consisting of incontinence devices, barrier birth control devices, douches, contraceptive sponges, and tampon applicators.
27 . The non-absorbent article as set forth in claim 13 wherein the first active ingredient reduces the formation of TSST-1 when the non-absorbent article is exposed to S. aureus by at least about 60%.
28 . The non-absorbent article as set forth in claim 13 further comprising a pharmaceutically active material selected from the group consisting of antimicrobials, antioxidants, anti-parasitic agents, antipruritics, astringents, local anaesthetics and anti-inflammatory agents.
29 - 111 . (canceled)
112 . The non-absorbent article as set forth in claim 13 further comprising an effective amount of a second active ingredient selected from the group consisting of glycerol monolaurate and myreth-3-myristate wherein said active ingredient is effective in substantially inhibiting the production of exoprotein from Gram positive bacteria.
113 - 141 . (canceled)Join the waitlist — get patent alerts
Track US2009035353A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.